|
Form Serial Number: |
DA20220421E00562
|
1.
Date of relevant event: |
19/04/2022 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
3.
Stock code: |
06600 |
4.
Name of listed corporation: |
SciClone Pharmaceuticals (Holdings) Ltd. |
5.
Class of shares: |
Ordinary Shares |
6.
Number of issued shares in class: |
685,334,263 |
7.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
Zhao |
(Other names) |
Hong |
|
|
|
10.
Name of director (Chinese): |
|
11.
Chinese Character Code as printed on HKID Card: |
|
|
24.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
Long position |
11031 | The number of shares in which you are interested has increased because: you became the holder of, wrote or issued equity derivatives under which (choose one): you have a right to take the underlying shares | |
|
|
4,600,000 |
|
|
|
|
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
25.
Total shares in listed corporation immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 23,435,900 | 3.42 |
|
|
26.
Total shares in listed corporation immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 28,035,900 | 4.09 |
|
|
27.
Capacity in which interests disclosed in Box 26 are held: |
Code describing capacity | Number of shares |
2201 | Interest of corporation controlled by you |
| |
| |
|
|
28.
Further information in derivative interests in listed corporation : |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 15/12/2018 | 14/12/2026 | USD | Nil | USD | 0.524 | | | 5,925,000 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 01/04/2020 | 31/03/2028 | USD | Nil | USD | 0.524 | | | 831,210 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 01/07/2020 | 30/06/2028 | USD | Nil | USD | 0.524 | | | 4,500,000 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 18/04/2023 | 18/04/2030 | HKD | Nil | HKD | 7.892 | | | 2,000,000 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 18/04/2024 | 18/04/2030 | HKD | Nil | HKD | 7.892 | | | 2,000,000 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 18/04/2023 | | HKD | Nil | | | | | 300,000 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 18/04/2024 | | HKD | Nil | | | | | 300,000 |
|
|
29.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
|
30.
Further information in relation to interests of corporations controlled by Director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
Zhoushan Kangnuo Equity Investment Partnership Enterprise (Limited Partnership) (舟山康諾股權投資合夥企業(有限合夥) | 中國(浙江)自由貿易試驗區舟山市定海區舟山港綜合保稅區企業服務中心305-55010室 | Zhao Hong | 40.96 | N | |
Beijing Convergence Management Consulting LLP (Limited Partnership) (北京諾盛衡康管理諮詢合夥企業(有限合夥) | 11A638, 11F, Inner 101, Building 13, 4th Area, Wangjing East District, Chaoyang District, Beijing, China | Zhoushan Kangnuo Equity Investment Partnership Enterprise (Limited Partnership) (舟山康諾股權投資合夥企業(有限合夥) | 99.99 | N | |
Convergence International Holdings Ltd. | Craigmuir Chambers, Road Town, Tortola, VG 1110, British Virgin Islands | Beijing Convergence Management Consulting LLP (Limited Partnership) (北京諾盛衡康管理諮詢合夥企業(有限合夥) | 100.00 | Y | |
|
|
31.
Further information in relation to interests held by Director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
| | |
|
|
32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
Names of Trust | Address | Status code | Number of shares |
| | | |
|
|
33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
Names of other parties | Address | Number of shares |
| | |
Total number of shares in which a director is interested under sections 317 and 318 | |
|
|
34.
Supplementary information: |
|
35.
Log/Serial Number of the previous form: |
|
36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
Date of filing this Form 3A: |
21/04/2022 (dd/mm/yyyy)
|
|